CCR2: A characteristic chemokine receptor in normal and pathological intestine.
CCR2
Colorectal cancer
Inflammatory bowel disease
Scientometric
Stromal-cell
Journal
Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
10
05
2023
revised:
25
06
2023
accepted:
01
07
2023
medline:
11
8
2023
pubmed:
13
7
2023
entrez:
12
7
2023
Statut:
ppublish
Résumé
C-C motif chemokine receptor 2 (CCR2), together with its ligands, especially C-C motif ligand 2 (CCL2), to which CCR2 has the highest affinity, form a noteworthy signaling pathway in recruiting macrophages for the immune responses among variegated disorders in vivo environment. Scientometric methods are used to analyze intestine-related CCR2 expression. We describe the current knowledge on biological function of CCR2 in physiological intestine in three dimensions, namely its effects on stromal cells, angiogenesis, and remodeling. However, anomalous expression of CCR2 has also been conveyed to correlate with detrimental outcomes in intestine, such as infective colitis, inflammatory bowel disease, carcinogenesis, and colon-related metastasis. In this article, we briefly summarize recent experimental works on CCR2 and its ligands, mostly CCL2, in intestinal-related physiological and pathological states to ravel out their working mechanisms in intestinal diseases.
Identifiants
pubmed: 37437448
pii: S1043-4666(23)00170-9
doi: 10.1016/j.cyto.2023.156292
pii:
doi:
Substances chimiques
Ligands
0
Receptors, CCR2
0
Chemokines
0
Chemokine CCL2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
156292Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.